Similar articles

• [Role of nitric oxide in ophthalmic diseases].

  Gerkowicz M, Kosior-Jarecka E, Kozioł-Montewka M. Gerkowicz M, et al. Klin Oczna. 2005;107(7-9):533-6. Klin Oczna. 2005. PMID: 16417016 Review. Polish.
• [Nitric oxide (NO) and vascular oxidative stress. New pathologic mechanisms and blood vessel diseases].

  Lauer N, Harrison DG, Kojda G. Lauer N, et al. Med Monatsschr Pharm. 1999 Dec;22(12):382-7. Med Monatsschr Pharm. 1999. PMID: 10628148 Review. German. No abstract available.
• [Nitric oxide].

  Kobayashi N, Matsuoka H. Kobayashi N, et al. Nihon Rinsho. 2007 Apr 28;65 Suppl 4:180-5. Nihon Rinsho. 2007. PMID: 17511074 Japanese. No abstract available.
• Antioxidant treatment for heart failure: friend or foe?

  Thomson MJ, Frenneaux MP, Kaski JC. Thomson MJ, et al. QJM. 2009 May;102(5):305-10. doi: 10.1093/qjmed/hcn160. Epub 2008 Dec 17. QJM. 2009. PMID: 19095676 Review.
• [The clinical significance of a study of the antioxidative status in ophthalmology].

  Semes'ko SG. Semes'ko SG. Vestn Oftalmol. 2005 May-Jun;121(3):44-7. Vestn Oftalmol. 2005. PMID: 16075633 Review. Russian. No abstract available.